Article Information
History
- April 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Upinder Kaur1,
- Bisweswar Ojha1,
- Bhairav Kumar Pathak1,
- Anup Singh2,
- Kiran R Giri1,
- Amit Singh1,
- Agniva Das1,
- Anamika Misra2,
- Ashish Kumar Yadav3,
- Sankha Shubhra Chakrabarti2,# and
- Sangeeta Kansal4,*
- 1Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
- 2Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
- 3Center of Biostatistics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
- 4Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
- ↵*Corresponding author: Prof Sangeeta Kansal, Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India, PIN-221005 Email: sangeetakansalbhu{at}gmail.com Phone: +919415223697
- ↵#Co-corresponding author: Dr SS Chakrabarti, Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India, PIN-221005 Email: sankha.geriatrics{at}gmail.com Phone: +919935615563
Posted April 07, 2021.
A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India
